(BUSINESS WIRE)--Pfizer Inc announced today that in recognition for its approach to improving the environment, the company was named to the Climate Disclosure Leadership Index (CDLI) by the Carbon Disclosure Project (CDP), a not-for-profit coalition of more than 315 global investors. Pfizer was one of 68 Fortune 500 companies -- and the only pharmaceutical company -- named in the CDLI, a prestigious honor roll for global corporations addressing the challenges of climate change.

“Pfizer has set itself apart from its peers by its thorough and comprehensive climate change disclosure and its voluntary reductions in greenhouse gas emissions and commitment to renewable energy,” CDP Chief Executive Paul Dickinson noted.

"The advancement of good health occurs through the innovation, production and distribution of medicines, but also through the preservation of a healthy environment,” said Steve Brooks, vice president of Global Environment Health & Safety Operations for Pfizer. “Through the hard work of our energy teams and the commitment of hundreds of colleagues worldwide, Pfizer has been able to conserve energy and use energy more efficiently, which has lead to a reduction in our carbon footprint.”

Pfizer has had a company standard requiring the conservation of energy and reduction of greenhouse gases since 1996. In 2002, Pfizer became a charter member of the Climate Leaders Program, a collaboration between the United States Environmental Protection agency and industry that aims to develop long-term, comprehensive climate change strategies and sets greenhouse gas emissions reduction goals. As a Climate Leader, Pfizer established a company-wide goal of reducing CO2 emissions by 35% per million dollars of sales by the end of 2007 from the baseline year of 2000. The company is also evaluating and implementing a number of projects that generate electricity from clean energy sources.

Pfizer Inc: Working for a healthier world™

Founded in 1849, Pfizer is the world's largest research-based pharmaceutical company taking new approaches to better health. We discover, develop, manufacture and deliver quality, safe and effective prescription medicines to treat and help prevent disease for both people and animals. We also partner with healthcare providers, governments and local communities around the world to expand access to our medicines and to provide better quality health care and health system support. At Pfizer, more than 90,000 colleagues in more than 90 countries work every day to help people stay happier and healthier longer and to reduce the human and economic burden of disease worldwide.